Literature DB >> 18460448

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.

Ping Lei1, Maen Abdelrahim, Sung Dae Cho, Shengxi Liu, Sudhakar Chintharlapalli, Stephen Safe.   

Abstract

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes (C-DIMs) activate the orphan receptors peroxisome proliferator-activated receptor gamma (PPARgamma) and Nur77 and induce receptor-dependent and -independent apoptotic pathways in colon and other cancer cells. Structure-activity studies show that the p-bromo (DIM-C-pPhBr) and p-fluoro (DIM-C-pPhF) analogs, which exhibit minimal activation of Nur77 and PPARgamma, induce expression of CCAAT/enhancer-binding protein homologous protein (CHOP/GADD153) in colon cancer cells. Moreover, among a series of bromo and fluoro C-DIM analogs, their induction of CHOP was dependent on the position of the phenyl substituents (para >/= meta >/= ortho) and required a free indole group. DIM-C-pPhBr and DIM-C-pPhF not only induced CHOP but also activated death receptor 5 (CHOP dependent), cleavage of caspase 8 and poly (ADP ribose) polymerase (PARP) that is consistent with activation of the extrinsic pathway of apoptosis. These responses were associated with the activation of c-jun N-terminal kinase (JNK) pathway since inhibition of JNK inhibited induction of the extrinsic apoptotic pathway by these C-DIMs. However, in contrast to classical inducers of endoplasmic reticulum (ER) stress such as tunicamycin and thapsigargin, the C-DIM compounds did not induce glucose-related protein 78 that is a marker of ER stress. Proapoptotic and anticarcinogenic effects were also observed in athymic nude mice bearing RKO cell xenografts and treated with 30 mg/kg/day DIM-C-pPhBr and this was accompanied by increased JNK phosphorylation in the tumors. Thus, the anticarcinogenic activity of DIM-C-pPhBr in colon cancer cells and tumors is related to a novel ER stress-independent activation of JNK.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460448      PMCID: PMC2574736          DOI: 10.1093/carcin/bgn103

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  37 in total

Review 1.  Tripartite management of unfolded proteins in the endoplasmic reticulum.

Authors:  K Mori
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

Review 2.  The unfolding tale of the unfolded protein response.

Authors:  Y Ma; L M Hendershot
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

3.  An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.

Authors:  Y Imai; M Soda; H Inoue; N Hattori; Y Mizuno; R Takahashi
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

4.  Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.

Authors:  Y Imai; M Soda; R Takahashi
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

5.  ORP150 protects against hypoxia/ischemia-induced neuronal death.

Authors:  M Tamatani; T Matsuyama; A Yamaguchi; N Mitsuda; Y Tsukamoto; M Taniguchi; Y H Che; K Ozawa; O Hori; H Nishimura; A Yamashita; M Okabe; H Yanagi; D M Stern; S Ogawa; M Tohyama
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 6.  The unfolded protein response and Alzheimer's disease.

Authors:  K Imaizumi; K Miyoshi; T Katayama; T Yoneda; M Taniguchi; T Kudo; M Tohyama
Journal:  Biochim Biophys Acta       Date:  2001-05-31

7.  Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.

Authors:  Siavosh Mahboobi; Steffen Teller; Herwig Pongratz; Harald Hufsky; Andreas Sellmer; Alexander Botzki; Andrea Uecker; Thomas Beckers; Silke Baasner; Christoph Schächtele; Florian Uberall; Matthias U Kassack; Stefan Dove; Frank-D Böhmer
Journal:  J Med Chem       Date:  2002-02-28       Impact factor: 7.446

8.  Salicylates trigger protein synthesis inhibition in a protein kinase R-like endoplasmic reticulum kinase-dependent manner.

Authors:  Aristóbolo M Silva; Die Wang; Anton A Komar; Beatriz A Castilho; Bryan R G Williams
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

9.  A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.

Authors:  Chunhua Qin; Derek Morrow; Jessica Stewart; Kyle Spencer; Weston Porter; Roger Smith; Timothy Phillips; Maen Abdelrahim; Ismael Samudio; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

10.  Proteasome inhibitors disrupt the unfolded protein response in myeloma cells.

Authors:  Ann-Hwee Lee; Neal N Iwakoshi; Kenneth C Anderson; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

View more
  21 in total

1.  Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.

Authors:  Xi Li; Syng-Ook Lee; Stephen Safe
Journal:  Biochem Pharmacol       Date:  2012-03-03       Impact factor: 5.858

2.  Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer.

Authors:  Nkechi Ichite; Mahavir Chougule; Apurva R Patel; Tanise Jackson; Stephen Safe; Mandip Singh
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

3.  Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.

Authors:  Marcia I Dawson; Mao Ye; Xihua Cao; Lulu Farhana; Qiong-Ying Hu; Yong Zhao; Li Ping Xu; Alice Kiselyuk; Ricardo G Correa; Li Yang; Tingjun Hou; John C Reed; Pamela Itkin-Ansari; Fred Levine; Michel F Sanner; Joseph A Fontana; Xiao-Kun Zhang
Journal:  ChemMedChem       Date:  2009-07       Impact factor: 3.466

4.  Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.

Authors:  Kyungsil Yoon; Syng-Ook Lee; Sung-Dae Cho; Kyounghyun Kim; Shaheen Khan; Stephen Safe
Journal:  Carcinogenesis       Date:  2011-03-01       Impact factor: 4.944

5.  Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth.

Authors:  Sung Dae Cho; Syng-Ook Lee; Sudhakar Chintharlapalli; Maen Abdelrahim; Shaheen Khan; Kyungsil Yoon; Ashish M Kamat; Stephen Safe
Journal:  Mol Pharmacol       Date:  2009-12-18       Impact factor: 4.436

6.  3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Kyung-Won Min; Xiaobo Zhang; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2012-07-21       Impact factor: 6.048

Review 7.  Targeting NR4A1 (TR3) in cancer cells and tumors.

Authors:  Syng-Ook Lee; Xi Li; Shaheen Khan; Stephen Safe
Journal:  Expert Opin Ther Targets       Date:  2011-01-05       Impact factor: 6.902

8.  Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes.

Authors:  Ping Lei; Maen Abdelrahim; Sung Dae Cho; Xinyi Liu; Xingi Liu; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

Review 9.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

10.  Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.

Authors:  A A Goldberg; V I Titorenko; A Beach; K Abdelbaqi; S Safe; J T Sanderson
Journal:  Invest New Drugs       Date:  2013-05-25       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.